Repligen
RGEN
163.81
-6.48
-3.81%
Repligen
US · RGEN
#1445 by market cap
Listed 1970
163.81
-6.48
-3.81%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Repligen
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
- Founded
- 1981
- CEO
- Mr. Olivier Loeillot
- Employees
- 2,000
- Headquarters
- Waltham, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- repligen.com
Company profile
- Exchange
- US
- Symbol
- RGEN
- Market-cap rank
- #1445
- Listing date
- 1970-01-01
- Market cap
- 10.47B
- Float cap
- 9.99B
- Shares out
- 63.92M
- Float shares
- 60.96M
Sectors & themes
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Repligen discussion 0 comments